India’s top drug regulator is considering new mandatory warning labels for morning-after pills, advising limited use and clearer guidance on risks and alternatives
New Delhi: India’s expert drug panel has recommended stricter warning labels on emergency contraceptive pills, proposing clear advisories on limited use and the need for alternative contraceptive methods.
The move comes as regulators weigh stronger oversight of emergency contraception amid concerns from several states.
Also Read
Why the panel wants stricter warnings
An expert committee under the Central Drugs Standard Control Organisation (CDSCO), chaired last month by Drug Controller General of India Rajeev Singh Raghuvanshi, has advised that morning-after pills should carry boxed warnings stating they should not be used more than twice a month. The panel also recommended the addition of a clear statement that these pills do not offer protection against HIV or sexually transmitted infections.
The committee has suggested that these warnings appear prominently on the primary packaging, outer carton and package insert. Users should also be urged to consult registered medical practitioners for appropriate long-term contraceptive options.
State-level concerns driving the push
The recommendation follows calls from several states, particularly Tamil Nadu, to tighten access to emergency contraceptives. Tamil Nadu’s drug authorities have raised concerns about potential misuse among young women and reported cases of side effects, including heavy menstrual bleeding. The state has repeatedly urged the Centre to shift emergency contraceptive pills from Schedule K to Schedule H of the Drugs and Cosmetics Rules, 1945, which would make them prescription-only.
However, gender-rights advocates have cautioned that such measures might act as a “shadow-ban”, limiting access to vital reproductive health tools and undermining women’s autonomy.
Emergency contraceptive pills, which typically contain levonorgestrel, have been available in India since 2003. They are about 85 per cent effective when taken within 72 hours of unprotected intercourse. Popular brands include i-pill and Unwanted-72.
India’s broader contraceptive framework
India regulates both hormonal and non-hormonal oral contraceptives.
Non-hormonal pills such as Chhaya and Saheli, approved since 1990, are taken weekly and use centchroman (ormeloxifene) to prevent sperm from reaching the egg. These are regarded as relatively safe, low-side-effect options.
Hormonal contraceptives include combined oral pills containing oestrogen and progestogen, progestin-only pills and emergency contraceptive pills. Daily-use hormonal contraceptives are intended for routine birth control, while emergency pills are designed solely for occasional use.
Experts note that side effects of emergency contraceptives—such as nausea, fatigue and temporary menstrual irregularities—are generally short-lived and resolve within one cycle.
The proposed tightening of labels indicates a balancing act between ensuring safer use and maintaining access. As consultations progress, policymakers face the task of addressing state concerns while safeguarding women’s reproductive choices.
Published: 05 Dec 2025, 11:16 am IST
Related Topics
Subscribe to our Newsletter
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.